Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 0.88% | 93.92 | 1.3% | $988.55m | |
| BIIB | Biogen Inc. | 2.45% | 229.89 | 1.3% | $619.18m | |
| AMGN | Amgen Inc. | 1.22% | 180.48 | 1.3% | $474.61m | |
| GILD | Gilead Sciences, Inc. | 2.13% | 64.14 | 0.9% | $448.87m | |
| ILMN | Illumina, Inc. | 1.49% | 319.20 | 3.5% | $295.43m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.80% | 349.99 | 2.6% | $291.08m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.18% | 174.61 | 1.9% | $236.35m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 4.30% | 135.68 | 2.0% | $176.60m | |
| EXAS | Exact Sciences Corporation | 0.27% | 95.39 | 25.3% | $169.11m | |
| A | Agilent Technologies, Inc. | 1.23% | 76.72 | 1.6% | $147.38m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.74% | 120.22 | 14.7% | $129.47m | |
| ONCE | Spark Therapeutics, Inc. | 0.64% | 111.38 | 11.2% | $116.56m | |
| INCY | Incyte Corporation | 0.57% | 73.94 | 2.5% | $97.68m | |
| IONS | Ionis Pharmaceuticals, Inc. | 0.72% | 73.86 | 8.3% | $96.82m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.21% | 85.31 | 4.3% | $92.88m |
Company Profile
Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engages in finding treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA.